TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2. (Q40070558)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

apoptotic process

0 references

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Alessandro Natoni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Marion MacFarlane

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Satoshi Inoue

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Renata Walewska

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Aneela Majid

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Deborah Knee

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

David R Stover

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Gerald M Cohen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

0 references

publication date

8 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

139

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

568-577

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922877%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

The promise of TRAIL--potential and risks of a novel anticancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Enhanced apoptosis and tumor regression induced by a direct agonist antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

The CD95(APO-1/Fas) DISC and beyond

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Inhibition of Histone Deacetylase Class I but not Class II Is Critical for the Sensitization of Leukemic Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06852.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40070558&oldid=1483046422"